Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Winning cash for taking blood pressure meds increases compliance
About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.
Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial
The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.
SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

The findings were presented at TCT 2021 and published in the New England Journal of Medicine.

The policy covers all healthcare providers that participate in Medicare or Medicaid.

"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said.

These individuals are less likely to benefit from COVID-19 vaccines, according to a recent study from the Centers for Disease Control and Prevention.

The study's authors said that policies should be put in place to provide better support for these individuals.

One facility saw vascular surgeon consultations increase by more than 500% over the course of 15 years.

Researchers examined data from the CardioMEMS Post Approval Study, sharing their findings in JACC: Heart Failure.

The team behind the new pilot study said additional research is still necessary to confirm its findings.